The Chicago Entrepreneur

[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-light"]
Menu
Top Stories

Amgen’s stock falls 4% as analysts say drug updates lag competitors

The biotech offered an update on two drugs in development, but analysts said they’re not as effective as existing treatments.

Previous post Buy the stocks of these companies helping fuel the ‘AI gold rush,’ analyst says
Next post Expect crypto bulls to flock back to this space now that the Fed is cutting rates

More Stories